UnitedHealth stock plunges on report of DoJ Medicare Advantage probe UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation. UNH Jobs, Employment and Work News
News Transcripts & Insights SEC Filings Press Releases Related AnalysisZBH Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -16.47% Zimmer Biomet Holdings, Inc. price and volume Combination chart with 2 data series. Chart represents Zimmer Biomet Holdings, Inc. price and volume...
Stock Investing News, Analysis and Tips Dec 28, 2023 1:05 PM EST Morningstar's 10 most undervalued stocks with key market advantages The research firm assigns wide moats to companies it thinks have competitive advantages that will last at least 20 years. ETSYIFFPFE Stock Investing News, Analys...
CEO:Ivan Tornos Website:https://www.zimmerbiomet.com Ticker:ZBH Company type:Public Revenues ($M):$7,394 Profits ($M):$1,024 Market value ($M):$27,117 Number of employees:18,000 Market value as of March 28, 2024.Zimmer Biomet Holdings stock chartTrack...
JYo: $Zimmer Biomet(ZBH)$ More good news coming![Silence] 2021-10-11 发表 公司简介 Manufactures and distributes orthopedic reconstructive implants 中文名: 捷迈邦美 公司名称: Zimmer Biomet Holdings, Inc. 所属行业: 健康科技 / 医学专科 交易所: 纽约证券交易所 股票分析 最近更新于 2025...
齐默巴奥米特控股将在摩根大通医疗会议上发言;网络直播时间为东部时间上午11:15。 RTTNews01/14 23:16 联博集团维持齐默巴奥米特控股(ZBH.US)持有评级,维持目标价111美元 联博集团分析师Lee Hambright维持$Zimmer Biomet Holdings(ZBH.US)$持有评级,维持目标价111美元。根据TipRanks数据显示,该分析师近一年总胜率为...
齐默巴奥米特控股的目标价格维持在每股140.00美元,由JMP证券提供。 道琼斯02/08 01:30 RBC资本将Zimmer Biomet的目标价格从130美元调整至125美元,维持跑赢大盘评级 MT Newswires02/07 23:42 高盛将齐默巴奥米特控股的价格目标从118美元调整为115美元 MT Newswires02/07 22:04 齐默巴奥米特控股 分析师评级 Benzinga...
Use Our Stock Screener Invested Advice, rankings and one great story every day. Sign Up Sign up to receive the latest updates from U.S. News & World Report and our trusted partners and sponsors. By clicking submit, you are agreeing to our Terms and Conditions & Privacy Policy....
免费提供齐默巴奥米特控股 (ZBH) 公告,第一时间获取公司最新公告,了解齐默巴奥米特控股 (ZBH) 的最新消息与重大动态。
高盛将齐默巴奥米特控股的目标股价从115美元调整至120美元,维持中立评级。 根据FactSet调查的分析师,齐默巴奥米特控股(ZBH)获得了超配的平均评级和120.20美元的平均目标价。 MT Newswires03/27 18:26 分析齐默巴奥米特控股近期的空头持仓 齐默巴奥米特控股(纽交所:ZBH)的开空比例自上次报告以来下降了11.66%。该...